Squarepoint Ops LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,578,766
-12.1%
57,947
-28.2%
0.00%
-33.3%
Q2 2023$1,796,910
+291.0%
80,760
+256.9%
0.01%
+200.0%
Q4 2022$459,554
-46.6%
22,627
-32.6%
0.00%
-50.0%
Q3 2022$861,000
-41.5%
33,584
-45.7%
0.00%
-50.0%
Q2 2022$1,471,000
-42.0%
61,845
-45.1%
0.01%
-27.3%
Q1 2022$2,538,000
+78.2%
112,694
+56.7%
0.01%
+175.0%
Q4 2021$1,424,000
+474.2%
71,895
+470.1%
0.00%
+300.0%
Q3 2021$248,000
-85.1%
12,610
-80.1%
0.00%
-91.7%
Q4 2020$1,660,000
+444.3%
63,448
+250.3%
0.01%
+140.0%
Q2 2020$305,000
-60.5%
18,113
-72.1%
0.01%
-75.0%
Q1 2020$773,000
+121.5%
65,026
+163.3%
0.02%
+566.7%
Q3 2019$349,000
-81.9%
24,697
-85.8%
0.00%
-84.2%
Q2 2019$1,933,000
+14.7%
173,371
+20.7%
0.02%
+5.6%
Q1 2019$1,686,000
+13.2%
143,583
+28.7%
0.02%
+5.9%
Q4 2018$1,490,000
+63.4%
111,539
+92.3%
0.02%
+41.7%
Q2 2018$912,000
-83.1%
57,997
-82.3%
0.01%
-86.0%
Q1 2018$5,389,000
+903.5%
327,591
+1002.0%
0.09%
+855.6%
Q4 2017$537,000
+8.9%
29,727
+16.3%
0.01%0.0%
Q3 2017$493,000
+5.8%
25,561
-35.3%
0.01%0.0%
Q2 2017$466,000
+174.1%
39,500
+154.6%
0.01%
+80.0%
Q1 2017$170,000
-43.0%
15,516
-62.2%
0.01%
-58.3%
Q4 2016$298,00041,1000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders